Basit öğe kaydını göster

dc.contributor.authorHamuryudan, Vedat
dc.contributor.authorHatemi, Gulen
dc.contributor.authorOzguler, Yesim
dc.contributor.authorTuzun, Hasan
dc.contributor.authorSeyahi, Emire
dc.contributor.authorYurdakul, Sebahattin
dc.contributor.authorYazici, Hasan
dc.contributor.authorUgurlu, Serdal
dc.contributor.authorMelikoglu, Melike
dc.contributor.authorAkman, Canan
dc.date.accessioned2021-03-04T10:50:52Z
dc.date.available2021-03-04T10:50:52Z
dc.date.issued2015
dc.identifier.citationHamuryudan V., Seyahi E., Ugurlu S., Melikoglu M., Hatemi G., Ozguler Y., Akman C., Tuzun H., Yurdakul S., Yazici H., "Pulmonary artery involvement in Behcet's syndrome: Effects of anti-Tnf treatment", SEMINARS IN ARTHRITIS AND RHEUMATISM, cilt.45, sa.3, ss.369-373, 2015
dc.identifier.issn0049-0172
dc.identifier.otherav_6f403869-b65b-4b64-9790-a2ad21b060aa
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/76785
dc.identifier.urihttps://doi.org/10.1016/j.semarthrit.2015.06.008
dc.description.abstractObjectives: Anti-TNF agents are being increasingly used in patients with Behcet's syndrome (BS) when conventional immunosuppressives fail. However, experience with anti-TNF treatment on pulmonary artery involvement (PAI) of BS is limited.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titlePulmonary artery involvement in Behcet's syndrome: Effects of anti-Tnf treatment
dc.typeMakale
dc.relation.journalSEMINARS IN ARTHRITIS AND RHEUMATISM
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume45
dc.identifier.issue3
dc.identifier.startpage369
dc.identifier.endpage373
dc.contributor.firstauthorID61066


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster